Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Athersys stock

Learn how to easily invest in Athersys stock.

Athersys is a biotechnology business based in the US. Athersys shares (ATHX) are listed on the NASDAQ and all prices are listed in US Dollars. Athersys employs 24 staff and has a trailing 12-month revenue of around $146,000.

How to buy Athersys stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ATHX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Athersys stock price (NASDAQ: ATHX)

Use our graph to track the performance of ATHX stocks over time.

Athersys shares at a glance

Information last updated 2023-09-27.
Latest market close$0.33
52-week range$0.26 - $2.76
50-day moving average $0.50
200-day moving average $0.95
Wall St. target price$5.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.67

Buy Athersys stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Athersys stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Athersys price performance over time

Historical closes compared with the close of $0.33 from 2023-09-27

1 week (2023-09-21) 17.86%
1 month (2023-08-28) -28.26%
3 months (2023-06-28) -57.69%
6 months (2023-03-28) -74.02%
1 year (2022-09-28) -79.75%
2 years (2021-09-28) -76.26%
3 years (2020-09-28) 2.08
5 years (2018-09-28) 2.1

Athersys financials

Revenue TTM $146,000
Gross profit TTM $-65,566,000
Return on assets TTM -104.09%
Return on equity TTM -1276.02%
Profit margin 0%
Book value $-1.71
Market Capitalization $8.9 million

TTM: trailing 12 months

Athersys share dividends

We're not expecting Athersys to pay a dividend over the next 12 months.

Have Athersys's shares ever split?

Athersys's shares were split on a 1:25 basis on 28 August 2022. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Athersys shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Athersys shares which in turn could have impacted Athersys's share price.

Athersys share price volatility

Over the last 12 months, Athersys's shares have ranged in value from as little as $0.256 up to $2.76. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Athersys's is -0.7358. This would suggest that Athersys's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Athersys has bucked the trend.

Athersys overview

Athersys, Inc. , a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K. K.

Frequently asked questions

What percentage of Athersys is owned by insiders or institutions?
Currently 0.497% of Athersys shares are held by insiders and 11.305% by institutions.
How many people work for Athersys?
Latest data suggests 24 work at Athersys.
When does the fiscal year end for Athersys?
Athersys's fiscal year ends in December.
Where is Athersys based?
Athersys's address is: 3201 Carnegie Avenue, Cleveland, OH, United States, 44115-2634
What is Athersys's ISIN number?
Athersys's international securities identification number is: US04744L2051
What is Athersys's CUSIP number?
Athersys's Committee on Uniform Securities Identification Procedures number is: 04744L106

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site